Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Mannkind Shares Dip After FDA Group Raises Afrezza Concerns
Mannkind Shares Dip After FDA Group Raises Afrezza Concerns
Mannkind Shares Dip After FDA Group Raises Afrezza Concerns
Submitted by
admin
on March 28, 2014 - 1:00pm
Source:
FOX Business
News Tags:
MannKind
FDA
Afrezza
insulin
diabetes
Headline:
Mannkind Shares Dip After FDA Group Raises Afrezza Concerns
Do Not Allow Advertisers to Use My Personal information
